MEERA CLINICALTRIALLINK
Live / Applied — Statement of use — registration review complete (as of 05 Oct 2026)
What this means for you
Not registered yet, but its 01 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97817528
- Mark type
- Word mark
- Filed
- 01 Mar 2023
- Published for opposition
- 09 Jan 2024
- Attorney of record
- Stephen Prince
Goods and services
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software for connecting stakeholders, namely, clinical research organizations, patients, trial clinic sites, and primary care physicians, for clinical trials to improve recruitment and retention, data collection, and analytics
Owner
- Meera Therapeutics, Inc, La Verne, CA, US
- Meera Therapeutics, Inc, La Verne, CA, US
Prosecution history
- 05 Oct 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Oct 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Oct 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 05 Oct 2026 — EXAMINER'S AMENDMENT ENTERED
- 05 Oct 2026 — EXAMINERS AMENDMENT E-MAILED
- 05 Oct 2026 — SU-EXAMINER'S AMENDMENT WRITTEN
- 20 Jun 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Jun 2026 — NON-FINAL ACTION E-MAILED
- 20 Jun 2026 — SU - NON-FINAL ACTION - WRITTEN
- 04 Jun 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Feb 2026 — USE AMENDMENT FILED
- 04 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Aug 2025 — SOU EXTENSION 3 GRANTED